MOORE TIMOTHY L. — SEC Form 4 filings
SEC reporting owner CIK 1669207. 8 Form 4 filings on record with FilingPulse; latest filed 2026-02-26.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-01-31 to 2026-02-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 14,746 shares, $25,216 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 14,746 shares @ $1.71 ($25,216) in Allogene Therapeutics, Inc., filed 2025-02-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | Chief Technical Officer | 3 | — | 1 leg · 14,746 sh · $25,216 | 3 |
| BIOLIFE SOLUTIONS INC (BLFS) | Director | 3 | — | — | 3 |
| CERUS CORP (CERS) | Director | 2 | — | — | 2 |
Form 4 filings — MOORE TIMOTHY L.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-26 | 4 | BIOLIFE SOLUTIONS INC (BLFS) | Grant/award (A): 8,170 | EDGAR |
| 2025-06-04 | 4 | CERUS CORP (CERS) | Grant/award (A): 60,000 @ $0 | EDGAR |
| 2025-03-20 | 4 | BIOLIFE SOLUTIONS INC (BLFS) | Grant/award (A): 6,876 | EDGAR |
| 2025-02-05 | 4 | Allogene Therapeutics, Inc. (ALLO) | Sale (S): 14,746 @ $1.71 | EDGAR |
| 2024-06-06 | 4 | CERUS CORP (CERS) | Grant/award (A): 40,000 @ $5 | EDGAR |
| 2024-04-24 | 4 | Allogene Therapeutics, Inc. (ALLO) | Tax withholding (F): 17,360 @ $3.47 | EDGAR |
| 2024-03-12 | 4 | BIOLIFE SOLUTIONS INC (BLFS) | Grant/award (A): 11,264 | EDGAR |
| 2024-01-31 | 4 | Allogene Therapeutics, Inc. (ALLO) | Grant/award (A): 96,600 @ $0 · Grant/award (A): 341,515 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1669207 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →